Drug Type Monoclonal antibody |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Releviate Therapeutics LLCStartup |
Active Organization Releviate Therapeutics LLCStartup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Small Fiber Neuropathy | Phase 1 | US | Releviate Therapeutics LLCStartup | 13 Mar 2022 |
Neuralgia | Preclinical | US | Releviate Therapeutics LLCStartup | 13 Mar 2022 |